<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116904</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0682</org_study_id>
    <nct_id>NCT05116904</nct_id>
  </id_info>
  <brief_title>Smith Magenis Syndrome Study</brief_title>
  <acronym>SMS</acronym>
  <official_title>Chronobiological Characterization of Smith Magenis Syndrome in Paediatric Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Smith Magenis Syndrome (SMS) is a complex disorder characterized by severe neurological,&#xD;
      psychological and behavioral disorders including sleep-wake rhythm disorders. It is a rare&#xD;
      disease with a prevalence of 1/25 000.&#xD;
&#xD;
      The sleep disorders observed could be the consequence of a general dysregulation of the&#xD;
      circadian system, since these patients show an inversion of the melatonin secretion profile.&#xD;
      In SMS, the peak of melatonin is observed at 12 o'clock, whereas it is nocturnal in healthy&#xD;
      subjects (3-4 o'clock in the morning). Daylight plays a important role in circadian&#xD;
      regulation by inducing an inhibition of melatonin secretion via the suprachiasmatic nuclei of&#xD;
      the hypothalamus. This mechanism could be affected in SMS children, explaining the lag of&#xD;
      melatonin profile.&#xD;
&#xD;
      These sleep-wake disturbances cycle could play a significant role in learning deficits and in&#xD;
      the frequency and severity of behavioral abnormalities observed in SMS.&#xD;
&#xD;
      In this project, investigators propose to study the mechanisms involved in the sleep-wake&#xD;
      cycle disorders observed in Smith Magenis children, in particular by evaluating the quality&#xD;
      of the pupillary reflex using a pupillometer. The pupillary reflex is a simple and&#xD;
      non-invasive method to test light sensitivity and the photobiological mechanisms involved.&#xD;
&#xD;
      In this way, investigators want to evaluate the diurnal profile of the pupillary reflex in&#xD;
      children with Smith Magenis syndrome in relation to the diurnal melatonin profile.&#xD;
&#xD;
      Investigators will complete this study by determining the chronobiological profile of Smith&#xD;
      Magenis patients by measuring different variables:&#xD;
&#xD;
        -  Diurnal cortisol and amylase profile&#xD;
&#xD;
        -  24h body temperature and heart rate profile&#xD;
&#xD;
        -  Urinary cortisol and 6-sulfatoxymelatonin (major metabolite of melatonin) profiles&#xD;
&#xD;
        -  Daytime sleepiness profile measured subjectively by questionnaire and objectively via a&#xD;
           waking EEG recording.&#xD;
&#xD;
        -  Actimetry at home&#xD;
&#xD;
        -  Polysomnography&#xD;
&#xD;
        -  A neurocognitive and behavioural assessment&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of the percentage change between pupil diameter at the end of light exposure and before exposure</measure>
    <time_frame>One day</time_frame>
    <description>This measurement will allow to evaluate the diurnal profile of the pupillary reflex and will be measured by a NeuroLight pupillometer (IDMed).&#xD;
This measurement will be done every 2 hours from 8am to 8pm, for one day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of salivary melatonin levels</measure>
    <time_frame>One day</time_frame>
    <description>This measurement will allow to evaluate the diurnal melatonin profile and will be evaluated using saliva samples.&#xD;
This measurement will be done every 2 hours from 8am to 8pm, for one day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Salivary cortisol levels</measure>
    <time_frame>Every 2 hours from 8am to 8pm, for one day</time_frame>
    <description>Salivary cortisol levels will be evaluated using saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Amylase levels</measure>
    <time_frame>Every 2 hours from 8am to 8pm, for one day</time_frame>
    <description>Amylase levels will be evaluated using saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Urinary 6-sulfatoxymelatonin level</measure>
    <time_frame>over 24hours</time_frame>
    <description>Urinary 6-sulfatoxymelatonin level will be evaluated using urinary samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Urinary cortisol level</measure>
    <time_frame>over 24hours</time_frame>
    <description>Urinary cortisol level will be evaluated using urinary samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Variations in body temperature in degrees</measure>
    <time_frame>over 24hours</time_frame>
    <description>Body temperature will be measured by ibuttonR placed on the surface of the skin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Assessment of sleepiness by questionnaire (numerical score)</measure>
    <time_frame>Every 2 hours from 8am to 8pm, for one day</time_frame>
    <description>The Karolinska questionnaire will be carried out at the time of salivary sampling and pupil diameter measurement and the score obtained will be compared with the salivary melatonin level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Assessment of sleepiness by spectral analysis (EEG)</measure>
    <time_frame>Every 2 hours from 8am to 8pm, for one day</time_frame>
    <description>Somnolence will be evaluated by calculating power spectrum in several frequency bands.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile : Sleep assessment by actimetry</measure>
    <time_frame>2 weeks</time_frame>
    <description>Home activity monitor during an outpatient recording with a watch in order to assess the sleep wake rhythm at home</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the chronobiological profile :Sleep assessment by Polysomnography</measure>
    <time_frame>24 hours</time_frame>
    <description>Polysomnography during hospitalization in order to assess the structure of sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological assessment</measure>
    <time_frame>One day</time_frame>
    <description>WISC +/- Vineland</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Smith-Magenis Syndrome</condition>
  <arm_group>
    <arm_group_label>Children with Smith Magenis Syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment</intervention_name>
    <description>Pupil reflex and melatonin profile, circadian profile assessment</description>
    <arm_group_label>Children with Smith Magenis Syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Genetically confirmed Smith Magenis syndrome (microdeletion of the short arm of&#xD;
             chromosome 17 or mutation of the RAI1 gene; obtained by FISH, CGH-array or molecular&#xD;
             biology)&#xD;
&#xD;
          -  Aged 7-12 years&#xD;
&#xD;
          -  Consent form signed by the parent(s)&#xD;
&#xD;
          -  Requiring a sleep assessment in the Hopital Femme MÃ¨re Enfant paediatric sleep unit of&#xD;
             Pr Franco&#xD;
&#xD;
          -  Affiliation to a social security system.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Associated ophthalmological disorders that do not allow the photomotor reflex to be&#xD;
             studied: optic neuritis, glaucoma and retinitis pigmentosa.&#xD;
&#xD;
          -  Dyschromatopsia detected in consultation with a rapid Ishihara test adapted to the&#xD;
             child's cognitive level, if necessary supplemented by a test performed by&#xD;
             ophthalmologists.&#xD;
&#xD;
          -  Algic child (risk of measurement bias: when a patient is in pain his pupils dilate and&#xD;
             we observe a greater amplitude in the photomotor reflex), defined by a score on the&#xD;
             FPS-R Face Scale &gt;4/10.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia FRANCO, Pr</last_name>
    <phone>0427856052</phone>
    <phone_ext>+33</phone_ext>
    <email>patricia.franco@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service Ãpilepsie-Sommeil-Explorations Fonctionnelles Neurologiques PÃ©diatriques HÃ´pital Femme-MÃ¨re-Enfant HCL</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Patricia FRANCO, Pr</last_name>
      <phone>0427856052</phone>
      <phone_ext>+33</phone_ext>
      <email>patricia.franco@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Patricia FRANCO, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GeÌnoPsy, Reference Center for Diagnosis and Management of Genetic Psychiatric Disorders, Centre Hospitalier le Vinatier and EDR-Psy Q19 Team (Centre National de la Recherche Scientifique &amp; Lyon 1 Claude Bernard University)</name>
      <address>
        <city>Bron</city>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pr Caroline Demily Dr Alice POISSON</last_name>
      <phone>caroline.DEMILY@ch-le-vinatier</phone>
      <email>alice.POISSON@-le-vinatier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 21, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep disorders</keyword>
  <keyword>Chronobiology</keyword>
  <keyword>Smith Magenis Syndrome</keyword>
  <keyword>Paediatrics</keyword>
  <keyword>Pupillary reflex</keyword>
  <keyword>Circadian rhythm</keyword>
  <keyword>Melatonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Smith-Magenis Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

